These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11581121)

  • 1. NICE guidelines and the treatment of Alzheimer's disease: evidence-based medicine may be discriminatory.
    Stewart R
    Br J Psychiatry; 2001 Oct; 179():367. PubMed ID: 11581121
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE reiterates that people with mild Alzheimer's disease should not get drug treatment.
    Dyer C
    BMJ; 2009 Jun; 338():b2413. PubMed ID: 19525311
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer drugs: who benefits under NICE?
    Agnew T
    Nurs Older People; 2006 Dec; 18(11):7-8. PubMed ID: 17260590
    [No Abstract]   [Full Text] [Related]  

  • 4. NICE to see the bigger picture.
    Lancet Neurol; 2006 Feb; 5(2):103. PubMed ID: 16426980
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of mild Alzheimer's disease post-NICE.
    Connelly PJ; Passmore AP; Lawlor BA
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1262-3. PubMed ID: 17503543
    [No Abstract]   [Full Text] [Related]  

  • 6. NICE recommends drugs for moderate Alzheimer's disease.
    Mayor S
    BMJ; 2006 Jan; 332(7535):195. PubMed ID: 16439382
    [No Abstract]   [Full Text] [Related]  

  • 7. NICE vindicated in UK's High Court.
    Horton R
    Lancet; 2007 Aug; 370(9587):547-8. PubMed ID: 17707735
    [No Abstract]   [Full Text] [Related]  

  • 8. NICE guidelines unfair for Alzheimer's disease.
    Lowery K
    Br J Nurs; 2001 Nov 8-21; 10(20):1314. PubMed ID: 11873223
    [No Abstract]   [Full Text] [Related]  

  • 9. Patients with mild Alzheimer's disease should have access to drugs, says draft NICE guidance.
    Kmietowicz Z
    BMJ; 2010 Oct; 341():c5562. PubMed ID: 20926475
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rational pharmaco-therapeutic algorithms for the management of Alzheimer's disease].
    Belousov IuB; Danilov AN; Zyrianov SK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):59-64. PubMed ID: 21465821
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of NICE guidelines on the diagnosis and treatment of Alzheimer's disease among general medical hospital inpatients.
    Cairns R; Evans J; Prince M
    Int J Geriatr Psychiatry; 2004 Aug; 19(8):800-2. PubMed ID: 15290705
    [No Abstract]   [Full Text] [Related]  

  • 12. Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease.
    Ballard C; Corbett A; Sharp S
    Expert Rev Neurother; 2011 Mar; 11(3):327-9. PubMed ID: 21375436
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten years of cholinesterase inhibitors.
    Rodda J; Walker Z
    Int J Geriatr Psychiatry; 2009 May; 24(5):437-42. PubMed ID: 19367617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?
    Schneider LS
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):9-13. PubMed ID: 16353164
    [No Abstract]   [Full Text] [Related]  

  • 15. Lawyers claim "concession" over drug prescribing for Alzheimer's disease.
    Dyer C
    BMJ; 2007 Jul; 335(7609):11. PubMed ID: 17615199
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing drugs for Alzheimer's disease in primary care: managing cognitive symptoms.
    Drug Ther Bull; 2014 Jun; 52(6):69-72. PubMed ID: 24924683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease. Three-score years and then?
    Bryan J
    Health Serv J; 1998 Aug; 108(5619):suppl 4-5, 7-8. PubMed ID: 10185456
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment for Alzheimer's disease in people with learning disabilities: NICE guidance.
    Arshad P; Sridharan B; Brown R
    Br J Psychiatry; 2001 Jul; 179():74. PubMed ID: 11435274
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacotherapy of Alzheimer's disease--an evidence based approach].
    Boban M; Mahović-Lakusić D; Babić T
    Lijec Vjesn; 2004; 126(7-8):211-4. PubMed ID: 15754792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NICE insiders criticise Alzheimer's drug decision.
    Gould M
    Health Serv J; 2006 Oct; 116(6028):8. PubMed ID: 17086921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.